Stephen Anastasiou has over 20 years of experience in general management, marketing and strategic planning within the healthcare industry. His experience incorporates medical diagnostics, pharmaceuticals, hospital, dental and over-the-counter products, with companies including the international pharmaceutical company Bristol-Myers Squibb (NYSE: BMY).
While working with KPMG Peat Marwick as a management consultant, Mr Anastasiou had led project teams in a diverse range of market development and strategic planning projects within the public and private sectors.
He is also a director and shareholder of several unlisted private companies across a variety of industry sectors including healthcare and funds management. Mr Anastasiou's companies have participated in several corporate transactions involving business units and brands of multinational and Australian companies.